Evidence map›Paper›PMID 31002310›Full record

ArticleEndocrinology2019

Growth Hormone Induces Colon DNA Damage Independent of IGF-1.

Vera Chesnokova, Svetlana Zonis, Robert J Barrett, John P Gleeson, Shlomo Melmed

Open access · bronzeAbstract read
In one paragraph

Article in Endocrinology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. GH and Senescence: A New Understanding of Adult GH Action.Journal of the Endocrine Society · 2022
    Review
  12. Review
  13. Article
  14. Benefits of Living Without Growth Hormone.The journals of gerontology. Series A, Biological sciences and medical sciences · 2021
    Article
  15. Growth Hormone and Aging: New Findings.The world journal of men's health · 2021
    Review
  16. Article
  17. Article
  18. Review
  19. Crosstalk between the growth hormone/insulin-like growth factor-1 axis and the gut microbiome: A new frontier for microbial endocrinology.Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society
    Review
  20. Growth hormone in the tumor microenvironment.Archives of endocrinology and metabolism
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Vera ChesnokovaPituitary Center, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California.
Svetlana ZonisPituitary Center, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California.
Robert J BarrettDepartment of Medicine, Board of Governors Regenerative Medicine Institute, Cedars-Sinai Medical Center, Los Angeles, California.
John P GleesonDepartment of Medicine, Board of Governors Regenerative Medicine Institute, Cedars-Sinai Medical Center, Los Angeles, California.
Shlomo MelmedPituitary Center, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California.
Cedars-Sinai Medical Center · US

Funding

Mechanisms for GH action on epithelial cellsR01DK113998 · NIDDK · CEDARS-SINAI MEDICAL CENTER · PI SHLOMO MELMED · 2018 to 2026
$3.0M
NIDDK NIH HHS R01 DK113998
6 · The paper itself

Abstract

DNA damage occurs as a result of environmental insults and aging and, if unrepaired, may lead to chromosomal instability and tumorigenesis. Because GH suppresses ataxia-telangiectasia mutated kinase phosphorylation, decreases DNA repair, and increases DNA damage accumulation, we elucidated whether GH effects on DNA damage are mediated through induced IGF-1. In nontumorous human colon cells, GH, but not IGF-1, increased DNA damage. Stably disrupted IGF-1 receptor (IGF-1R) by lentivirus-expressing short hairpin RNA in vitro or treatment with the IGF-1R phosphorylation inhibitor picropodophyllotoxin (PPP) in vitro and in vivo led to markedly induced GH receptor (GHR) abundance, rendering cells more responsive to GH actions. Suppressing IGF-1R triggered DNA damage in both normal human colon cells and three-dimensional human intestinal organoids. DNA damage was further increased when cells with disrupted IGF-1R were treated with GH. Because GH induction of DNA damage accumulation appeared to be mediated not by IGF-1R but probably by more abundant GH receptor expression, we injected athymic mice with GH-secreting xenografts and then treated them with PPP. In these mice, high circulating GH levels were associated with increased colon DNA damage despite disrupted IGF-1R activity (P < 0.01), whereas GHR levels were also induced. Further confirming that GH effects on DNA damage are directly mediated by GHR signaling, GHR-/- mice injected with PPP did not show increased DNA damage, whereas wild-type mice with intact GHR exhibited increased colon DNA damage in the face of IGF-1 signaling suppression. The results indicate that GH directly induces DNA damage independent of IGF-1.

Indexed as

AnimalsCell Line, TumorColonDNA DamageDose-Response Relationship, DrugGrowth HormoneHumansInsulin-Like Growth Factor IMiceMice, KnockoutPhosphorylationReceptor, IGF Type 1Receptors, SomatotropinSignal TransductionGrowth HormoneInsulin-Like Growth Factor IReceptor, IGF Type 1Receptors, Somatotropin

Identifiers

PMID31002310
PMCPMC6530523
OpenAlexW2937038356

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.